Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 CAD | -2.48% | -0.63% | -53.13% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.13% | 18.78M | |
+42.22% | 58.71B | |
-2.89% | 41.31B | |
+36.13% | 39.2B | |
-10.22% | 27.4B | |
+11.08% | 26.55B | |
-22.39% | 18.98B | |
+0.92% | 12.51B | |
+26.21% | 12.08B | |
+21.65% | 11.94B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Presenting Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib